Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.336 USD | -91.91% | +52.68% | -25.50% |
Financials (USD)
Sales 2024 * | 65.3M | Sales 2025 * | 6.25M | Capitalization | 18.66M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.29 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
0.77
x | P/E ratio 2025 * |
-0.49
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.61% |
Latest transcript on MEI Pharma, Inc.
1 day | -91.91% | ||
1 week | +52.68% | ||
Current month | +52.68% | ||
1 month | +53.49% | ||
3 months | +14.97% | ||
6 months | -28.27% | ||
Current year | -25.50% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- MEIP Stock
- 0JW9 Stock